Ladenburg Thalmann Initiates Coverage on Optimer Pharmaceuticals (OPTR) with a Buy
Tweet Send to a Friend
Ladenburg Thalmann initiates coverage on Optimer Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
